50bp deletion in the promoter for superoxide dismutase 1 (SOD1) reduces SOD1 expression in vitro and may correlate with increased age of onset of sporadic amyotrophic lateral sclerosis

References

• Rosen DR. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993; 364: 362
   PubMed Web of Science ®Google Scholar
• Cudkowicz ME, McKenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis (see comments). Ann Neurol. 1997; 41: 210–21
   PubMed Web of Science ®Google Scholar
• Mui S, Rebeck GW, McKenna-Yasek D, Hyman BT, Brown RH, Jr. Apolipoprotein E epsilon 4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol. 1995; 38: 460–3
   PubMed Web of Science ®Google Scholar
• Li YJ, Pericak-Vance MA, Haines JL, Siddique N, McKenna-Yasek D, Hung WY, et al. Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics. 2004; 5: 209–13
   PubMed Web of Science ®Google Scholar
• Fogh I, Rijsdijk F, Andersen PM, Sham PC, Knight J, Neale B, et al. Age at onset in SOD1-mediated amyotrophic lateral sclerosis shows familiality. Neurogenetics. 2007; 8: 235–6
   PubMedGoogle Scholar
• Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, et al. ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis. Nat Genet. 2006; 38: 411–3
   PubMed Web of Science ®Google Scholar
• Schymick JC, Talbot K, Traynor BJ. Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet. 2007; 16: R233–42
   Web of Science ®Google Scholar
• van Es MA, van Vught PW, Blauw HM, Franke L, Saris CG, Andersen PM, et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol. 2007; 6: 869–77
   PubMed Web of Science ®Google Scholar
• Lederer CW, Torrisi A, Pantelidou M, Santama N, Cavallaro S. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics. 2007; 8: 26
   PubMed Web of Science ®Google Scholar
• Kasperaviciute D, Weale ME, Shianna KV, Banks GT, Simpson CL, Hansen VK, et al. Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain. 2007; 130: 2292–301
   PubMed Web of Science ®Google Scholar
• Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med. 2007; 357: 775–88
   PubMed Web of Science ®Google Scholar
• Broom WJ, Parton MJ, Vance CA, Russ C, Andersen PM, Hansen V, et al. No association of the SOD1 locus and disease susceptibility or phenotype in sporadic ALS. Neurology. 2004; 63: 2419–22
   PubMed Web of Science ®Google Scholar
• Lee AJ, McInerney PJ, Mullins PR. STATCALC: an integrated statistics system for the Apple II microcomputer. Comput Programs Biomed. 1984; 18: 265–72
   PubMedGoogle Scholar
• Dignam JD, Martin PL, Shastry BS, Roeder RG. Eukaryotic gene transcription with purified components. Methods Enzymol. 1983; 101: 582–98
   PubMed Web of Science ®Google Scholar
• Braveman MW, Chen-Plotkin AS, Yohrling GJ, Cha JH. Chromatin immunoprecipitation technique for study of transcriptional dysregulation in intact mouse brain. Methods Mol Biol. 2004; 277: 261–76
   PubMedGoogle Scholar
• Hyman BT, Trojanowski JQ. Consensus recommendations for the post mortem diagnosis of Alzheimer's disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. J Neuropathol Exp Neurol. 1997; 56: 1095–7
   PubMed Web of Science ®Google Scholar
• Broom WJ, Auwarter KE, Ni J, Russel DE, Yeh LA, Maxwell MM, et al. Two approaches to drug discovery in SOD1-mediated ALS. J Biomol Screen. 2006; 11: 729–35
   PubMed Web of Science ®Google Scholar
• Francis JW, Hosler BA, Brown RH, Jr, Fishman PS. Cu/Zn superoxide dismutase (SOD1): tetanus toxin fragment C hybrid protein for targeted delivery of SOD1 to neuronal cells. J Biol Chem. 1995; 270: 15434–42
   PubMed Web of Science ®Google Scholar
• Majoor-Krakauer D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet. 2003; 63: 83–101
   PubMed Web of Science ®Google Scholar
• Thaete LG, Crouch RK, Nakagawa F, Spicer SS. The immunocytochemical demonstration of Cu/Zn superoxide dismutase in the brain. J Neurocytol. 1986; 15: 337–43
   PubMedGoogle Scholar
• Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA. 1995; 92: 954–8
   PubMed Web of Science ®Google Scholar
• Lindenau J, Noack H, Possel H, Asayama K, Wolf G. Cellular distribution of superoxide dismutases in the rat CNS. Glia. 2000; 29: 25–34
   PubMed Web of Science ®Google Scholar
• Cova E, Cereda C, Galli A, Curti D, Finotti C, Di Poto C, et al. Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neurosci Lett. 2006; 399: 186–90
   PubMedGoogle Scholar
• Tan EK, Puong KY, Chan DK, Yew K, Fook-Chong S, Shen H, et al. Impaired transcriptional up-regulation of parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association. Hum Genet. 2005; 118: 484–8
   PubMedGoogle Scholar
• Ezzi SA, Urushitani M, Julien JP. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem. 2007; 102: 170–8
   PubMed Web of Science ®Google Scholar
• Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science. 1994; 264: 1772–5
   PubMed Web of Science ®Google Scholar
• Nagai M, Aoki M, Miyoshi I, Kato M, Pasinelli P, Kasai N, et al. Rats expressing human cytosolic Cu/Zn superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J Neurosci. 2001; 21: 9246–54
   PubMed Web of Science ®Google Scholar